Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post‐hoc analysis from a double‐blinded randomized controlled trial

Ähnliche Einträge

• Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
  von: Melissa‐Rosina Pasqua, et al.
  Veröffentlicht: (2025)
• Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double‐blind, randomised, placebo‐controlled cross‐over trial
  von: Luxcia Kugathasan, et al.
  Veröffentlicht: (2026)
• Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
  von: Ajenthen G. Ranjan, et al.
  Veröffentlicht: (2025)
• Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial
  von: Jingyu Wang, et al.
  Veröffentlicht: (2024)
• Retagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
  von: Lixin Guo, et al.
  Veröffentlicht: (2024)